Biblio

Found 24 results
Author Keyword Title Type [ Year(Asc)]
Filters: Author is Amit M Oza  [Clear All Filters]
2010
E. L. Trimble, Birrer, M. J., Hoskins, W. J., Marth, C., Petryshyn, R., Quinn, M., Thomas, G. M., Kitchener, H. C., Aghajanian, C., Alberts, D. S., Armstrong, D., Brown, J., Coleman, R. L., Colombo, N., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Hunsberger, S., Kaye, S. B., Ledermann, J. A., Lee, S., Look, K., Mannel, R., McNeish, I. A., Minasian, L. M., Oza, A. M., Paul, J., Poveda, A. M., Pujade-Lauraine, E., Schoenfeldt, M., Swart, A. Marie, von Gruenigen, V., and Wenzel, L. B., Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009., Int J Gynecol Cancer, vol. 20, no. 7, pp. 1290-8, 2010.
T. J. Perren, Swart, A. Marie, Pfisterer, J., Ledermann, J. A., Lortholary, A., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., and Oza, A. M., . ICON7: A phase III randomised Gynaecologic Cancer InterGroup trial of concurrent bevacizumab and chemotherapy followed by maintenance bevacizumab, versus chemotherapy alone in women with newly diagnosed epithelial ovarian, primary peritoneal or fallopia, Ann Oncol , vol. 21, no. Suppl 8, abstr LBA4, 2010.
H. Mackay, Brady, M. F., Oza, A. M., Reuss, A., Pujade-Lauraine, E., Swart, A. Marie, Siddiqui, N. Ahmad, Colombo, N., Bookman, M. A., Pfisterer, J., du Bois, A., and InterGroup, G. Cancer, Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer, Int J Gynecol Cancer, vol. 20, pp. 945-52, 2010.
S. A. Welch, Hirte, H., Elit, L., Schilder, R. J., Wang, L., Macalpine, K., Wright, J. J., and Oza, A. M., Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium, Int J Gynecol Cancer, vol. 20, pp. 787-93, 2010.
2005
A. du Bois, Quinn, M., Thigpen, T., Vermorken, J. B., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Neijt, J. P., Oza, A. M., Ozols, R., Parmar, M. K. B., Pecorelli, S., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Stuart, G. C. E., Trimble, E. L., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., and Wagner, U., 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)., Ann Oncol, vol. 16 Suppl 8, pp. viii7-viii12, 2005.
G. C. E. Stuart, Åvall-Lundqvist, E., du Bois, A., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Oza, A. M., Ozols, R., Parmar, M. K. B., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Trimble, E. L., Thigpen, T., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., Vermorken, J. B., and Wagner, U., 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration., Ann Oncol, vol. 16 Suppl 8, pp. viii36-viii38, 2005.
M. Quinn, Pfisterer, J., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Casado, A., Cervantes, A., Grenman, S., Harper, P., Oza, A. M., Pecorelli, S., Pujade-Lauraine, E., Trimble, E. L., Vasey, P. A., Wagner, U., ,, -OVAR, A. G. O., ,, ,, ,, ,, /NCRI, M. R. C., -CTG, N. C. I. C., ,, ,, -US, N. C. I., and , Integration of new or experimental treatment options and new approaches to clinical trials, Ann Oncol, vol. 16 Suppl 8, pp. viii30-viii35, 2005.
M. Quinn, Pfisterer, J., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Casado, A., Cervantes, A., Grenman, S., Harper, P., Oza, A. M., Pecorelli, S., Pujade-Lauraine, E., Trimble, E. L., Vasey, P. A., and Wagner, U., Integration of new or experimental treatment options and new approaches to clinical trials., Ann Oncol, vol. 16 Suppl 8, pp. viii30-viii35, 2005.
J. A. Green, F, D., Coens, C., S, L., Vergote, I. B., Eisenhauer, E., Bacon, M., W, C., van der Burg, M. E. L., and Oza, A. M., Prognostic value of clinical and molecular markers in advanced ovarian cancer: importance of residual disease. Translational study using tumor specimens from EORTC 55931/NCIC OV10 phase III randomized clinical trial. , Proc Am Soc Clin Oncol , vol. 23, no. 16S Part 1, 2005.